Abstract:Frequent activation of the AKT serine-threonine kinase in cancer confers resistance to therapy. AKT is activated by a multi-step process involving phosphatidylinositide (PtdIns) phosphate-mediated recruitment of AKT and its upstream kinases, including 3-Phosphoinositide-dependent kinase 1 (PDK1), to the inner surface of the cell membrane. PDK1 in the appropriate context phosphorylates AKT at threonine 308 (T308) to activate AKT. Whether PtdIns(3,4,5)Ps (PtdInsP3) binding and AKT membrane translocation mediate functions other than formation of a functional PDK1::AKT complex have not been fully elucidated. We fused complementary fragments of intensely fluorescent protein (IFP) to AKT1 and PDK1 to induce a stable complex to study the prerequisites of AKT1 phosphorylation and function. In the stabilized PDK1-IFPC::IFPN-AKT1 complex, AKT1 T308 phosphorylation was independent of PtdIns, as demonstrated by treatment with Phosphatidylinositol 3 Kinase (PI3K) inhibitors. Further when interaction with PtdIns and the cell membrane was prevented by creating PH-domain mutants of AKT1 (R25A) and PDK1 (R474A), AKT1 phosphorylation on T308 was maintained in the PDK1-IFPC::IFPN-AKT1 complex. The PDK1-IFPC::IFPN-AKT1 complex was sufficient for phosphorylation of known AKT substrates, and conferred resistance to inhibitors of PI3K (LY294002, PI103, GDC0941 and TGX286) but not inhibitors of the downstream TORC1 complex (rapamycin). Thus the locus of action of targeted therapeutics can be elucidated by the constitutively active AKT1 complex. Our data indicate that PtdIns and membrane localization are not required for AKT phosphorylation and activation, but rather serve to induce a functional physical interaction between PDK1 and AKT. The PDK1-IFPC::IFPN-AKT1 complex provides a cell-based platform to examine specificity of drugs targeting PI3K pathway components.

AKT/PKB Signaling: Navigating Downstream

AKT/PKB Signaling: Navigating the Network

Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival

How is the AKT/mTOR Pathway Involved in Cell Migration and Invasion?

Current Perspectives on Akt Akt-ivation and Akt-ions

Advances in protein kinase B signalling: AKTion on multiple fronts

AKT kinases as therapeutic targets

I Kappa B Kinase Epsilon And Tank-Binding Kinase 1 Activate Akt By Direct Phosphorylation

The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

Revving the engine: PKB/AKT as a key regulator of cellular glucose metabolism

The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism

Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--opportunities, Challenges, and Limitations.

PAK signaling in oncogenesis

AKT and ERK dual inhibitors: The way forward?

New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response

The PTEN–PI3K Axis in Cancer

Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability

Essential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis

Alterations of the AKT Pathway in Sporadic Human Tumors, Inherited Susceptibility to Cancer, and Overgrowth Syndromes

Physical Association of PDK1 with AKT1 is Sufficient for Pathway Activation Independent of Membrane Localization and Phosphatidylinositol 3 Kinase.

AKT and the Hallmarks of Cancer